ArticleInnovations in pharmacy2020

More Unnecessary Imaginary Worlds - Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease.

Paul C LangleyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.